2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Solid Neoplasms: new trials by email Literature Review of Solid Neoplasms trials Research Report on Solid Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Dazostinag, Pembrolizumab, Platinum - Solid Neoplasms | Phase 1 / Phase 2 | Completed | Takeda | 248 | 2020-07-22 | 2026-10-22 |
| Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) MK-7162, Pembrolizumab - Solid Neoplasms | Phase 1 | Completed | Merck Sharp & Dohme LLC | 33 | 2017-12-06 | 2021-11-15 |
pembrolizumab (2) · Fluorouracil (1) · Platinum (1)
Merck Sharp & Dohme LLC (1) · Takeda (1)
Canada (2) · Israel (2) · United States (2) · Austria (1) · China (1) · France (1) · Japan (1) · Poland (1) · Puerto Rico (1) · South Korea (1) · Switzerland (1) · United Kingdom (1)
2017 (1), 2023 (1)